Vimarsana
Biggest News Aggregation in the World

Page 24 - Bemis Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bemis Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bemis Group Today - Breaking & Trending Today

EMIS Group plc (EMIS) To Go Ex-Dividend on April 14th - Vimarsana News

EMIS Group plc (EMIS) To Go Ex-Dividend on April 14th

EMIS Group plc (LON:EMIS – Get Rating) announced a dividend on Thursday, March 17th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, April 14th will be given a dividend of GBX 17.60 ($0.23) per share on Tuesday, May 17th. This represents a dividend yield of 1.41%. The ex-dividend date of this dividend is Thursday, April 14th. […]

Should I buy or avoid this FTSE healthcare stock? - Vimarsana News

Should I buy or avoid this FTSE healthcare stock?

Jabran Khan delves deeper into this FTSE healthcare stock and decides if he would buy or avoid it for his holdings and why.

Source: fool.co.uk
Yorkshire firm mobilises 75 million Covid-19 vaccinations - Vimarsana News

Yorkshire firm mobilises 75 million Covid-19 vaccinations

Health-tech provider Emis has mobilised more than 75 million jabs in England since vaccinations were introduced this time last year.

Research and Markets: United Kingdom m-Health App Market Report 2021 Featuring Yecco, Emis Group, Ampersand & Ampersand, Handle My Health, Philips Healthcare, Apple, Medtronic - Vimarsana News

Research and Markets: United Kingdom m-Health App Market Report 2021 Featuring Yecco, Emis Group, Ampersand & Ampersand, Handle My Health, Philips Healthcare, Apple, Medtronic

The "United Kingdom m-Health App Market Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The United Kingdom m-Health app market is projected to grow at a CAGR

Emis trading in line with its expectations amid ongoing momentum | 6 May 2021 - Vimarsana News

Emis trading in line with its expectations amid ongoing momentum | 6 May 2021

6 May 2021 | 09:32am StockMarketWire.com - Healthcare software and systems group Emis said year-to-date performance remained in line with the its expectations. 'As previously stated, the group expects to grow in 2021 and to build market momentum with its new product developments, which will lead to opportunities for higher levels of growth in 2022 and beyond,' the company said. At 9:32am: [LON:EMIS] Emis Group PLC share price was 0p at 980p Story provided by StockMarketWire.com Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Latest share price and company detai...